Pascal Medical, who has purchased and installed twelve Husky systems to create a state-of-the-art medical device production facility in Dubna, Russia, with the goal of creating an industry-leading manufacturing organization, capable of replacing foreign-import medical products with premium quality domestic production.
GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
Only Healthcare Packaging EXPO gives your company exposure to the mega-audience of PACK EXPO Las Vegas—30,000 buyers from virtually every vertical market. The world’s top CPGs send engineers and managers to PACK EXPO in search of innovative approaches to packaging and production. It’s a great opportunity to offer creative applications for your product.
